The UK government has doubled the rate that pharma companies must repay on the sales of newer products to the National Health ...

Angelini Ventures has joined a syndicate of European life sciences investors to back Elkedonia, a French biotech developing a ...

South Korean biotech AriBio Co, specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of ...

Germany-based Arvato and Dutch immunology specialist argenx (Euronext: ARGX) have successfully achieved two important ...

Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...

China-based biotech Innogen is making a strategic pivot toward international visibility following regulatory clearance of its ...

Belgian drugmaker UCB (Euronext: UCB) today announced new three-year data from Phase III trials, and their open-label ...

Gilead Sciences has paused five clinical trials of its investigational HIV drugs GS-1720 and GS-4182 after the American medicines regulator raised safety concerns. The once-weekly oral regimen was ...

Spanish biotech SpliceBio has secured $135 million in series B financing to accelerate development of its experimental gene ...

Last month, the Future Health Report was presented at the World Health Assembly in Geneva, Switzerland. The report states ...

A fresh attempt to bring more pharmaceutical manufacturing back to US soil has put the sector on alert, as a new executive ...

Oxford, UK-based biotech SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease ...